Unicycive Therapeutics Ownership | Who Owns Unicycive Therapeutics?

Unicycive Therapeutics Ownership Summary

Unicycive Therapeutics is owned by 3.18% institutional investors, 5.22% insiders, and 91.60% retail investors. Blackrock is the largest institutional shareholder, holding 0.15% of UNCY shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.68% of its assets in Unicycive Therapeutics shares.

UNCY Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Unicycive Therapeutics	3.18%	5.22%	91.60%
Sector	Healthcare Stocks	488.17%	11.08%	-399.26%
Industry	Biotech Stocks	306.59%	11.10%	-217.69%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	51.84K	0.15%	$25.98K
Goldman sachs group	73.61K	0.08%	$58.46K
Bank of america corp /de/	223.00	0.00%	$112.00
Silverarc capital management	-	-	-
Renaissance	-	-	-
Tower research capital llc (trc)	-	-	-
Bvf inc/il	-	-	-
Two sigma securities	-	-	-
Soa wealth advisors, llc.	-	-	-
Bogart wealth	-	-	-

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Geode capital management	-	-	-
Silverarc capital management	-	-	-
Bogart wealth	-	-	-
Renaissance	-	-	-
Blackrock	51.84K	-	$25.98K
Tower research capital llc (trc)	-	-	-
Two sigma securities	-	-	-
Bvf inc/il	-	-	-
Soa wealth advisors, llc.	-	-	-
Scientech research	-	-	-

Top Buyers

Holder	Shares	% Assets	Change
Blackrock	51.84K	-	51.84K
Bank of america corp /de/	223.00	-	223.00
Bogart wealth	-	-	-60.00
Jpmorgan chase	-	-	-184.00
Wells fargo & company/mn	-	-	-196.00

Top Sellers

Holder	Shares	% Assets	Change
Vivo capital	-	-	-11.37M
Great point partners	-	-	-10.98M
Octagon capital advisors lp	-	-	-10.00M
Nantahala capital management	-	-	-9.39M
Logos global management lp	-	-	-5.08M

New Positions

Holder	Shares	% Assets	Change	Value
Blackrock	51.84K	-	51.84K	$25.98K
Bank of america corp /de/	223.00	-	223.00	$112.00

Sold Out

Holder	Change
Bogart wealth	-60.00
Jpmorgan chase	-184.00
Wells fargo & company/mn	-196.00
Citigroup	-587.00
Soa wealth advisors, llc.	-1.00K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2025	4	-87.10%	21,301,904	-65.48%	3	0.07%	1	-95.24%	2	-60.00%
Dec 31, 2024	30	7.14%	61,690,744	31.86%	69	2.51%	20	-9.09%	5	-
Sep 30, 2024	28	16.67%	46,786,564	146.28%	52	1.78%	22	100.00%	-	-100.00%
Jun 30, 2024	24	4.35%	18,997,260	-10.59%	54	0.73%	11	-26.67%	7	250.00%
Mar 31, 2024	23	43.75%	21,247,089	63.05%	86	5.43%	15	114.29%	2	-33.33%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	469.49K	3.68%	-10.26K
Vanguard Institutional Extnd Mkt Idx Tr	81.66K	0.64%	-37.21K
Fidelity Extended Market Index	27.70K	0.22%	-72.00
Fidelity Total Market Index	10.90K	0.09%	-
iShares Micro-Cap ETF	69.73K	0.06%	-
Vanguard Instl Ttl Stk Mkt Idx InstlPls	7.34K	0.06%	1.00
Fidelity Series Total Market Index	6.88K	0.05%	-
Spartan Extended Market Index Pool E	58.30K	0.05%	2.46K
Spartan Extended Market Index Pool F	6.16K	0.05%	-
Northern Trust Extended Eq Market Idx	5.66K	0.04%	2.00

Recent Insider Transactions

Date	Name	Role	Activity	Value
May 16, 2022	Schiller Brigitte		Buy	$12.38K

Insider Transactions Trends

Date	Buy	Sell
2025 Q3	-	-
2025 Q1	-	-
2024 Q4	-	-
2024 Q3	-	-
2024 Q2	-	-

UNCY Ownership FAQ

Who Owns Unicycive Therapeutics?

Unicycive Therapeutics shareholders are primarily institutional investors at 3.18%, followed by 5.22% insiders and 91.60% retail investors. The average institutional ownership in Unicycive Therapeutics's industry, Biotech Stocks , is 306.59%, which Unicycive Therapeutics falls below.

Who owns the most shares of Unicycive Therapeutics?

Unicycive Therapeutics’s largest shareholders are Blackrock (51.84K shares, 0.15%), Goldman sachs group (73.61K shares, 0.08%), and Bank of america corp /de/ (223 shares, 0.00%). Together, they hold 0.23% of Unicycive Therapeutics’s total shares outstanding.

Does Blackrock own Unicycive Therapeutics?

Yes, BlackRock owns 0.15% of Unicycive Therapeutics, totaling 51.84K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 25.98K$. In the last quarter, BlackRock increased its holdings by 51.84K shares, a 100.00% change.

Who is Unicycive Therapeutics’s biggest shareholder by percentage of total assets invested?

Geode capital management is Unicycive Therapeutics’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Unicycive Therapeutics shares, valued at 0$.

Who is the top mutual fund holder of Unicycive Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Unicycive Therapeutics shares, with 3.68% of its total shares outstanding invested in 469.49K Unicycive Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools